Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Treating hyponatremia in heart failure
Steven R. Goldsmith
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treating hyponatremia in heart failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Outcomes
16%
Aquaresis
16%
Arginine Vasopressin
50%
Arginine Vasopressin Antagonist
33%
Clinical Trials
16%
Congestion
16%
Congestive Heart Failure
100%
Dilutional Hyponatremia
16%
Diuretics
16%
Edema
16%
Electrolyte
16%
Electrolyte Excretion
16%
Free Water Clearance
16%
Heart Failure
100%
Hyponatremia
100%
Non-selective
16%
Pathophysiologic Processes
16%
Renal Collecting Ducts
16%
Smooth muscle Myocytes
16%
Urine Electrolytes
16%
Urine Volume
16%
V2 Antagonist
50%
V2 Receptor
16%
Vascular Smooth muscle Cells
16%
Ventricular Preload
16%
Water Retention
16%
Medicine and Dentistry
Adverse Outcome
16%
Argipressin
83%
Clinical Trial
16%
Collecting Duct
16%
Congestive Heart Failure
100%
Diuretics
16%
Edema
16%
Electrolyte Excretion
16%
Free Water Clearance
16%
Heart Preload
16%
Hyponatremia
100%
Patient with Congestive Heart Failure
16%
Receptor
16%
Vascular Smooth Muscle Cell
16%
Vasopressin Antagonist
33%
Vasopressin V2 Receptor
16%
Water Retention
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
14%
Argipressin
71%
Clinical Trial
14%
Congestive Heart Failure
100%
Diuretics
14%
Edema
14%
Hyponatremia
100%
Receptor
14%
Vasopressin Antagonist
28%
Vasopressin V2 Receptor
14%